Trump's deregulation agenda could include plans to support the domestic cannabis industry, according to one ally.
These three buy-rated cannabis stocks could be set to benefit as both leading presidential candidates show growing support for legalization.
These smaller, rapidly expanding companies have significant growth potential.
Even a small investment in great stocks could yield significant long-term returns.
The AdvisorShares Pure Cannabis ETF (YOLO) is gaining attention from penny stock traders due to its low price of under $5 per share, offering a cost-effective way to tap into the potential growth of the...
These two stocks have been quietly making strides and could be long-term winners.
Canopy Growth stock has surged over 100% in 2024. Despite its recent gains, CGC stock remains a high-risk bet, due to its weak fundamentals and negative profit margins.
Growth stocks such as Viking Therapeutics, Cresco Labs, and Alphatec Holdings continue to trade at a significant discount to analysts' consensus price target estimates.